Jump to content

Enallylpropymal

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 16:13, 2 April 2016 (Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Enallylpropymal
Clinical data
Other namesEnallylpropymal
ATC code
  • none
Identifiers
  • (RS)-1-Methyl-5-allyl-5-isopropyl-1,3-diazinane-2,4,6-trione
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.015.876 Edit this at Wikidata
Chemical and physical data
FormulaC11H16N2O3
Molar mass224.256 g/mol g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • O=C1NC(=O)N(C)C(=O)C1(C(C)C)CC=C
  • InChI=1S/C11H16N2O3/c1-5-6-11(7(2)3)8(14)12-10(16)13(4)9(11)15/h5,7H,1,6H2,2-4H3,(H,12,14,16)
  • Key:AXJXURWWUFZZKN-UHFFFAOYSA-N
  (verify)

Enallylpropymal (Narconumal) is a barbiturate derivative developed by Hoffman la Roche in the 1930s.[1] It has sedative and hypnotic effects and is considered to have a moderate abuse potential.[2]

References

  1. ^ US Patent 2072829
  2. ^ Eddy NB, Halbach H, Isbell H, Seevers MH. Drug dependence: Its significance and characteristics. Bulletin of the World Health Organisation. 1965;32:721-733.